PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.

about

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.

Item

http://www.wikidata.org/entity/Q52430614

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.

@en

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.

@nl

type

Item

label

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.

@en

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.

@nl

prefLabel

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.

@en

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.

@nl

P1476

PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.

@en

P2093

Anne Kresinsky

http://www.w3.org/2001/XMLSchema#string

Benadict Vincent Albert

http://www.w3.org/2001/XMLSchema#string

Christian Fabisch

http://www.w3.org/2001/XMLSchema#string

Daniela Reich

http://www.w3.org/2001/XMLSchema#string

Frank-D Böhmer

http://www.w3.org/2001/XMLSchema#string

Julia Drube

http://www.w3.org/2001/XMLSchema#string

Kathrin Halfter

http://www.w3.org/2001/XMLSchema#string

Markus Pfirrmann

http://www.w3.org/2001/XMLSchema#string

Sebastian Drube

http://www.w3.org/2001/XMLSchema#string

Thomas Ernst

http://www.w3.org/2001/XMLSchema#string

P2860

CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling

CD45 phosphatase is crucial for human and murine acute myeloid leukemia maintenance through its localization in lipid rafts

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study.

Inside the human cancer tyrosine phosphatome.

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia.

Protein-tyrosine phosphatases and cancer.

CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation

PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia

Resistance to imatinib: mutations and beyond.

P304

9442-9455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24253

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Hochhaus

Claudio Sorio

P577

2018-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29507701

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

5823647

http://www.w3.org/2001/XMLSchema#string